✦ LIBER ✦

Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma

✍ Scribed by Gerd Ritter; Erika Boosfeld; Rita Adluri; Michele Calves; Herbert F. Oettgen; Lloyd J. Old; Philip Livingston

Publisher: John Wiley and Sons
Year: 1991
Tongue: French
Weight: 786 KB
Volume: 48
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910480312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of the antibody response to imm

Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma

✍ Gerd Ritter; Erika Ritter-Boosfeld; Rita Adluri; Michele Calves; Shunlin Ren; Ro 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 603 KB

## Abstract Gangliosides expressed in malignant melanoma are potential targets for immunotherapy. Immunization of melanoma patients with vaccines containing purified GM2 ganglioside has resulted in induction of GM2 antibodies, and high titers of GM2 antibodies have correlated with increased surviva

Induction of antibodies against GD3 gang

Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21

✍ Govindaswami Ragupathi; Michael Meyers; Sucharita Adluri; Lisa Howard; Cristina 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 181 KB 👁 1 views

The gangliosides GD3, GD2 and GM2 are expressed on the cell surface of malignant melanomas, GD3 being the most abundant. We have shown that immunization of melanoma patients with GM2 adherent to Bacillus Calmette-Guerin (GM2/BCG) induced an IgM antibody response. Vaccines containing GM2-keyhole limp

Antibody response to influenza immunizat

Antibody response to influenza immunization in adult patients with malignant disease

✍ Richard A. Shildt; Dan W. Luedke; Michel N. Laham; George Kasai; Sami El-Beheri 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

A phase I study of anti-GD3 ganglioside

A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma

✍ Lori M. Minasian; Tzy Jyun Yao; Thomas A. Steffens; David A. Scheinberg; Linda W 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Analysis of therapeutic and immunologic

Analysis of therapeutic and immunologic effects of R24 anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma

✍ John M. Kirkwood; Ruth A. Mascari; Howard D. Edington; Michael S. Rabkin; Roger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

## BACKGROUND. Antitumor effects of antibodies against ganglioside antigens of melanoma have been reported, but neither optimal doses nor mechanisms have been established. ## METHODS. This Phase IB trial of the murine immunoglobulin IgG 3 monoclonal antibody R 24 against disialoganglioside GD3

Humoral and cell-mediated immune respons

Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to pha and antigens following immunization

✍ G. C. De Gast; T. H. The; H. Schraffordt Koops; H. A. Huiges; J. Oldhoff; H. O. 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB